Leaders in the field of interventional oncology are at the forefront of developing targeted, minimally invasive, image-guided treatments for localized solid tumors.
ClearStart•SVM™ received FDA clearance in December 2011.
At INTIO, we are providing these interventional oncology leaders with solutions for more effectively integrating medical imaging into the entire treatment cycle; not just for image-guidance, but also for planning, targeting, monitoring, and response assessment of solid tumors so that interventional oncologists can more accurately treat cancer.
Clinical science is engaged in a paradigm shift for how cancer is diagnosed and treated. Interventional oncologists are at the epicenter of this shift, where they are poised to revolutionize the treatment of solid tumors.